# \[143\] BREAST-CANCER-INHIBITORS

 - Variables: 71
 - Inputs: 26
 - Regulations: 223
 - Publication: https://doi.org/10.1158/0008-5472.CAN-21-1208
 - Source: https://github.com/jgtz/BreastCancerModelv2/blob/e018f50344b378e57f36ba9fcceda6611f2a71b8/Models/BreastCancerModel_ZanudoEtAl2020.sbml
 - Keywords: curated, repaired


### Modifications

Constant update functions of variables `Alpelisib`, `Everolimus`, `Trametinib`, `BCL2_T`, `BCLXL_T`, `MCL1_T`, `BIM_T`, `ER`, `ER_microenvironment`, `FOXA1`, `Fulvestrant`, `HER2`, `HER3_T`, `HER3_microenvironment`, `Ipatasertib`, `MYC_T`, `Navitoclax`, `Neratinib`, `PBX1`, `PDK1`, `PIM`, `Palbociclib`, `Rb_T`, `S63845`, `SGK1_T`, and `p27_T` were removed to make them canonical inputs. Finally, variables `E2F_3`, `pRb_3` and `Proliferation_4` were removed because they are unused.

### Model citation

```
@article{bbm-143,
	title={Cell Line--Specific Network Models of ER+ Breast Cancer Identify Potential PI3K$\alpha$ Inhibitor Resistance Mechanisms and Drug Combinations},
	author={G{\'o}mez Tejeda Za{\~n}udo, Jorge and Mao, Pingping and Alcon, Clara and Kowalski, Kailey and Johnson, Gabriela N and Xu, Guotai and Baselga, Jose and Scaltriti, Maurizio and Letai, Anthony and Montero, Joan and others},
	journal={Cancer research},
	volume={81},
	number={17},
	pages={4603--4617},
	year={2021},
	publisher={AACR}
}
```

